Abdakibart Shows Strong Early Efficacy in Hidradenitis Suppurativa
(MedPage Today) -- Phase II findings presented at the European Academy of Dermatology and Venereology meeting in Vienna showed promising early efficacy with abdakibart, an investigational interleukin (IL)-1 beta inhibitor, in patients...























